In the 1950s, Arthur Frommer indelibly changed Americans’ traveling habits when he published Europe on 5 Dollars a Day. Beyond giving would-be tourists new ideas for ways to keep an exciting trip inexpensive, Frommer delivered information that was hard to find from any other source. In a similar vein, the 2016 edition of Scientific American Worldview introduces the worldVIEWguide, providing an in-depth exploration of global biotechnology; and best of all, it’s free—available 365 days a year for zero dollars. We hope that this guidebook changes how entrepreneurs and scientists, government officials and investors, media professionals and policy analysts, and others see biotechnology’s burgeoning or bustling sites around the world. It includes a deep dive into the Scientific American Worldview Scorecard for all 54 countries measured, plus other data elements, including a few up-close-and-personal details.
The Scientific American Worldview Scorecard also delivers more data and analysis than ever, including a mini-Scorecard highlighting the innovation-building activity in Latin America. Now eight years in on our journey into life science’s global complexity, we learn more about the health and dynamics of this industry with every issue.
In some cases, particularly for people who do not work in the field, the impact of this industry and its products goes relatively unnoticed, and Bill Cannon explores the depth of that dilemma and how it might be solved. In other cases, everyday people get drawn into the world of biotechnology; Renee Morad shows readers how some of them became activists in the field when a health crisis visited their own families. Furthering the theme of “user engagement,” Michelle Gallaher uncovers how one of today’s most powerful communication tools—social media—is introducing many more audiences to the wonders and potential of bioscience.
To keep pushing ahead, however, the industry must keep educating and training a strong workforce. Eric Bender looks at a range of today’s training programs, describing both their strengths and weaknesses. He reports that education in the industry requires international knowledge. He writes: “Biotechnology educators … emphasize the need to keep in mind country-by-country issues within a global industry.”
One thing that concerns everyone in the biotechnology sector—in fact, scientists around the world—is the crisis in the reproducibility of research. So we asked five experts: In your opinion, how bad is the problem of reproducibility in scientific research and what should be done about it? This year’s worldVIEWpoint reveals their unique, thoughtful answers.
Each year, we delve deeper into the many facets of international biotechnology and find new ways to depict our findings—all spawned from the single goal of taking the annual pulse of this field. That “pulse,” just like a person’s, arises from a wide range of components, and some can be quantified better than others. So we dig up the data, interview the experts, mine the archives of articles, and then show you what we found—all depicted here, in the 2016 Scientific American Worldview.
This could never be attempted without our sponsors and partners —Johnson & Johnson, our Marquee Sponsor; Celgene Corporation; Invest Victoria; Covance; Merck KGaA, Darmstadt, Germany; GlaxoSmithKline; and the Biotechnology Innovation Organization—and we are grateful for their support, encouragement and shared mission of edifying global audiences to the ever-changing world of innovation.
Jeremy Abbate, Publishing Director
Mike May, Editorial Director
Yali Friedman, Head, Data Analytics
Enhanced with a new guidebook and region-specific ratings, the 2016 Scorecard ventures deeper than ever to track down the latest in biotech innovation